Bridging the uncertainty divide between academic and drug development

Academic Partnerships

IRAZÚ partners with individual Principal Investigator’s and university-based Centers of Excellence to accelerate translational research, IND-enabling studies and Phase 1 clinical trials.

Research Curation

IRAZÚ identifies and increases value of transformative intellectual property assets with a hands on approach

Business Model: Pharma Exits or New Company Formation

IRAZÚ either licenses with pharma companies for clinical development of lower risk, higher value IP assets or starts new companies in collaboration with pharma companies and venture capital groups